| A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma (NCT01826448) | Daiichi Sankyo | 2013-11-05 |
| An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors (NCT02038673) | Astellas Pharma Inc | 2013-11-05 |
| An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors (NCT01968109) | Bristol-Myers Squibb | 2013-11-05 |
| DC Vaccination for Postremission Therapy in AML (NCT01734304) | Ludwig-Maximilians - University of Munich | 2013-11-05 |
| Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer (NCT01987232) | Amgen | 2013-11-05 |
| A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer (NCT01876251) | Pfizer | 2013-11-04 |
| Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects (NCT01978613) | Novo Nordisk A/S | 2013-11-01 |
| A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects (NCT01981681) | Pfizer | 2013-11-01 |
| A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients (NCT01985191) | Sanofi | 2013-11-01 |
| BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects (NCT01977859) | AdventHealth Translational Research Institute | 2013-11-01 |
| The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study (NCT01999530) | Centre for Addiction and Mental Health | 2013-11-01 |
| A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation (NCT01728181) | University of Utah | 2013-11-01 |
| Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis (NCT02301884) | Gachon University Gil Medical Center | 2013-11-01 |
| Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients (NCT01997983) | UroGen Pharma Ltd. | 2013-11-01 |
| Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults (NCT02021968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-01 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (NCT01919684) | Ligand Pharmaceuticals | 2013-11-01 |
| EC17 for Intraoperative Imaging in Occult Ovarian Cancer (NCT02000778) | University of Pennsylvania | 2013-11-01 |
| Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study (NCT02128178) | Mansoura University | 2013-11-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions (NCT02965261) | Torrent Pharmaceuticals Limited | 2013-11-01 |
| Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers (NCT01589666) | Entegrion, Inc. | 2013-11-01 |
| EC17 for Intraoperative Imaging for Parathyroidectomy (NCT01996072) | University of Pennsylvania | 2013-11-01 |
| A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers (NCT01959594) | Pfizer | 2013-11-01 |
| Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma (NCT02002598) | Suzanne Lentzsch, MD | 2013-11-01 |
| A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors (NCT02020226) | Threshold Pharmaceuticals | 2013-11-01 |
| To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses. (NCT01958645) | AstraZeneca | 2013-11-01 |
| Japanese Phase 1 Study of BMS-844203 (CT322) (NCT01146171) | Bristol-Myers Squibb | 2013-11-01 |
| Neurophysiological Study of tDCS Effects in Healthy Volunteers (NCT02125422) | University of Liege | 2013-11-01 |
| Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy (NCT01996228) | Throne Biotechnologies Inc. | 2013-11-01 |
| A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer (NCT02015416) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2013-11-01 |
| An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7) (NCT01856218) | Ultragenyx Pharmaceutical Inc | 2013-11-01 |
| A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers (NCT01967966) | Genentech, Inc. | 2013-11-01 |
| Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents (NCT02128308) | Seoul National University Hospital | 2013-11-01 |
| Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy (NCT02285673) | Acibadem University | 2013-11-01 |
| Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors (NCT01968915) | Novartis Pharmaceuticals | 2013-11-01 |
| Genistein in Treatment of Metastatic Colorectal Cancer (NCT01985763) | Sofya Pintova | 2013-11-01 |
| A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors (NCT02009631) | AbbVie | 2013-11-01 |
| Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M (NCT02023606) | Supernus Pharmaceuticals, Inc. | 2013-11-01 |
| Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function (NCT01894256) | AstraZeneca | 2013-11-01 |
| Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD (NCT02167763) | Sebela Women's Health Inc. | 2013-11-01 |
| Improving Retreatment Success (IMPRESS) (NCT02114684) | Centre for the AIDS Programme of Research in South Africa | 2013-11-01 |
| A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS (NCT01986166) | Genentech, Inc. | 2013-11-01 |
| Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies (NCT02017613) | Rhizen Pharmaceuticals SA | 2013-11-01 |
| Early Serum Infliximab Levels in Severe Ulcerative Colitis. (NCT01971814) | University of California, San Francisco | 2013-11-01 |
| Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients (NCT01941316) | Cancer Research and Biostatistics Clinical Trials Consortium | 2013-11-01 |
| Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial (NCT02024984) | Ain Shams Maternity Hospital | 2013-11-01 |
| BNCT and IG-IMRT for Recurrent Head and Neck Cancer (NCT02004795) | Taipei Veterans General Hospital, Taiwan | 2013-11-01 |
| Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer (NCT01837329) | University of Rochester | 2013-11-01 |
| Walnut Oral Immunotherapy for Tree Nut Allergy (NCT01834352) | University of North Carolina, Chapel Hill | 2013-11-01 |
| Default BP Medication Intensification (NCT01994408) | Cedars-Sinai Medical Center | 2013-11-01 |
| A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802 (NCT01981005) | Hoffmann-La Roche | 2013-11-01 |
| A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes (NCT01981031) | Adocia | 2013-11-01 |
| A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (NCT02009878) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-11-01 |
| A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy (NCT02260115) | Actamax Surgical Materials LLC | 2013-11-01 |
| Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers (NCT01982604) | Mannkind Corporation | 2013-11-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443) | AIDS Malignancy Consortium | 2013-11-01 |
| Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (NCT01982643) | Walter Ling | 2013-11-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions (NCT02965274) | Torrent Pharmaceuticals Limited | 2013-11-01 |
| Antacid Interaction Study (NCT01982201) | Ardea Biosciences, Inc. | 2013-11-01 |
| Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension (NCT02226094) | OcuTherix, Inc. | 2013-11-01 |
| Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients (NCT02024074) | Emory University | 2013-11-01 |
| Regulation of Endogenous Glucose Production by Brain Insulin Action (NCT02131948) | University Health Network, Toronto | 2013-11-01 |
| A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol) (NCT01991678) | Nektar Therapeutics | 2013-11-01 |
| Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis (NCT01990157) | Theramab LLC | 2013-11-01 |
| CC100: Safety and Tolerability of Single Doses (NCT02050334) | Chemigen, LLC | 2013-11-01 |
| The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers (NCT01983358) | Jeil Pharmaceutical Co., Ltd. | 2013-11-01 |
| Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 (NCT01962935) | AstraZeneca | 2013-11-01 |
| Platelet-Rich Plasma vs Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint (NCT01920373) | Kaiser Permanente | 2013-11-01 |
| A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751 (NCT01981694) | Pfizer | 2013-11-01 |
| AZD6738 First Time in Patient Multiple Ascending Dose Study (NCT01955668) | AstraZeneca | 2013-11-01 |
| Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC (NCT02013778) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
| Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects (NCT01986608) | UCB Pharma SA | 2013-11-01 |
| Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge (NCT01969617) | H. Lundbeck A/S | 2013-11-01 |
| MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01991379) | Memorial Sloan Kettering Cancer Center | 2013-11-01 |
| A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics (NCT01925989) | Eli Lilly and Company | 2013-11-01 |
| Indocyanine Green for Solid Tumors (NCT02280954) | University of Pennsylvania | 2013-11-01 |
| Docetaxel and Lycopene in Metastatic Prostate Cancer (NCT01949519) | Medical University of South Carolina | 2013-11-01 |
| Evaluation of Two Types of PRP in Knee Osteoarthritis (NCT02923310) | University of Campinas, Brazil | 2013-11-01 |
| Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease (NCT01937468) | Dana-Farber Cancer Institute | 2013-11-01 |
| Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers (NCT01997879) | Aerie Pharmaceuticals | 2013-11-01 |
| Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients (NCT01994850) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
| Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell (NCT01980030) | Assistance Publique - Hôpitaux de Paris | 2013-11-01 |
| Abuse Potential Study of PF-00345439 (NCT01986283) | Pain Therapeutics | 2013-11-01 |
| Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers. (NCT03698045) | Laboratorios Sophia S.A de C.V. | 2013-11-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants (NCT01964872) | Janssen Cilag N.V./S.A. | 2013-11-01 |
| A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans (NCT01981928) | Astellas Pharma Europe B.V. | 2013-11-01 |
| Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People (NCT02308254) | Royal Adelaide Hospital | 2013-11-01 |
| Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT02046421) | University of Chicago | 2013-11-01 |
| High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors (NCT01941758) | Wake Forest University Health Sciences | 2013-11-01 |
| A Study of the Immune Response to Heplisav in Healthy Older Adults (NCT01999699) | Dynavax Technologies Corporation | 2013-11-01 |
| Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine (NCT01995617) | Genocea Biosciences, Inc. | 2013-11-01 |
| Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers (NCT02446340) | Kineta Inc. | 2013-11-01 |
| Pharmacokinetics of MP-3180 in Healthy Volunteers (NCT02098174) | MediBeacon | 2013-11-01 |
| A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers (NCT01980953) | Genentech, Inc. | 2013-11-01 |
| Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors (NCT01892046) | Esanex Inc. | 2013-11-01 |
| Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration (NCT02121353) | Pfenex, Inc | 2013-11-01 |
| A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT02056808) | Summit Therapeutics | 2013-11-01 |
| A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma (NCT01996202) | Duke University | 2013-11-01 |
| A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease (NCT01966666) | University of California, San Francisco | 2013-11-01 |
| Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies (NCT01998035) | Columbia University | 2013-11-01 |
| OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy (NCT02058017) | National University Hospital, Singapore | 2013-11-01 |